header-langage
简体中文
繁體中文
English
Tiếng Việt
한국어
日本語
ภาษาไทย
Türkçe
Scan to Download the APP
Partnered With:

Biopharmaceutical Publicly Traded Company ATAI Life Sciences Plans to Purchase $5 Million in BTC

BlockBeats News, March 21st, Biopharmaceutical publicly traded company ATAI Life Sciences announced that it will adopt a Bitcoin financial strategy, with plans to initially invest $5 million to purchase Bitcoin. In response to this news, ATAI's stock price briefly increased. The company's Chairman, Christian Angermayer, stated that the company plans to initially invest $5 million to purchase Bitcoin while also maintaining sufficient cash, short-term securities, and publicly traded equity to secure the company's operating funds until 2027.

举报 Correction/Report
RelatedRecommended
Talk to someone with a historical perspective on the digital community
"Halo has not yet taken a snapshot, so do it now."
Correction/Report
Submit
Add Library
Visible to myself only
Public
Save
Choose Library
Add Library
Cancel
Finish